TRC-253 | Interleukin Related interleukin-related.com

Product Name :
TRC-253

Search keywords :
JNJ-63576253

drugId :
null

Target Vo:
Androgen Receptor

Target Vo Short Name :
AR

Moa_Name:
Androgen Receptor antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Johnson & Johnson Innovative Medicine

Active Company_Name :
Janssen Pharmaceutical Nv

Active Indication_Name:
Prostatic Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
CD31 (YP5047) Mouse mAb Epigenetic Reader Domain
FAK Rabbit mAb Purity
TRIM21 Antibody (YA658): TRIM21 Antibody (YA658) is a non-conjugated and Mouse origined monoclonal antibody about 54 kDa, targeting to TRIM21 (5B9). It can be used for WB assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts